Effect of Chitin and Ascorbic Acid on Dietary Insect Iron Absorption

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorSwiss Distance University of Applied Sciences

About this trial

Iron is involved in many vital metabolic processes such as oxygen transport, electron transport in cells, DNA synthesis and repair, and muscle metabolism. However, iron deficiency and iron deficiency anemia continue to affect many people, particularly preschool children (\<5 years), adolescents, and pregnant and non-pregnant women of childbearing age. Iron deficiency is characterized by a lack of total iron stores in the body, which is mainly caused by insufficient dietary iron intake, physiologically increased iron requirements, poor intestinal iron absorption, or chronic blood loss. Animal foods are important sources of highly bioavailable iron in the human diet. Meeting human nutritional needs for the rapidly increasing world population while targeting food production within the planetary boundaries will require the identification of sustainable iron sources, such as edible insects. A previous iron absorption study showed that insect iron is absorbed moderately well. The present study will examine if and to which extent chitin, a polysaccharide within the insect biomass, inhibits iron absorption. In addition, the enhancing iron absorption of ascorbic acid on iron absorption from Tenebrio molitor larvae will be studied. This knowledge can support to optimize the composition of an insect-based meal to increase its iron absorption.

To distinguish iron absorption from insect biomass from other sources, insects are labeled with stable iron isotopes (Fe-57, Fe-58, Fe-54) and iron absorption in the blood is measured.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Female aged between 18-45 years

Normal BMI (18.5 - 24.9 kg/m2)

Body weight < 70 kg

Low iron status (being in the lower half of the serum ferritin distribution at screening)

Disqualifiers

Anaemia (Hb < 12 g/dL)

Inflammation (CRP > 5.0 mg/L)

Pregnancy or intention to become pregnant during the study or within 30 days after the discontinuation of the study intervention

Lactating up to 6 weeks before the study initiation

Trial design

Design model

Crossover

Treatments tested in this trial

  • Meal A

    Other intervention

    Vegetable soup prepared with dried intrinsically labeled T.molitor (isotopic iron 57, native chitin content = 1g)

  • Meal B

    Other intervention

    Vegetable soup prepared with dried intrinsically labeled T.molitor (isotopic iron 57) + 2g of extrinsically added chitin

  • Meal C

    Other intervention

    Vegetable soup prepared with dried intrinsically labeled T.molitor (isotopic iron 57) + ascorbic acid (4:1 ascorbic acid to iron molar ratio)

  • Meal D

    Other intervention

    Vegetable soup without insects with extrinsic addition of FeSO4 (isotopic iron 58)

  • Meal E

    Other intervention

    Vegetable soup without insects with extrinsic addition of FeSO4 (isotopic iron 58) + 1g of extrinsically added chitin

  • Meal F

    Other intervention

    Vegetable soup without insects with extrinsic addition of FeSO4 (isotopic iron 58) + 3g of extrinsically added chitin

  • Meal G

    Other intervention

    Vegetable soup without insects with extrinsic addition of FeSO4 (isotopic iron 54) + ascorbic acid (4:1 ascorbic acid to iron molar ratio)

Treatment groups

25 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.

Group A: T.molitor native chitinExperimental treatment 1 intervention
Group B: T.molitor high chitin levelExperimental treatment 1 intervention
Group C: T.molitor + Ascorbic AcidExperimental treatment 1 intervention
Group D: Control mealExperimental treatment 1 intervention
Group E: Control meal low chitinExperimental treatment 1 intervention
Group F: Control meal high chitinExperimental treatment 1 intervention
Group G: Control meal + Ascorbic AcidExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Fractional iron absorption

Fractional iron absorption will be calculated based on the shift in iron isotope ratio in red blood cells 14 to 16 days post administration of the isotopically labelled meals. Calculation of fractional iron absorption will take into account the principles of isotope dilution and the fact that iron isotopic labels are not monoisotopic.

Time frame
screening (-1), 16th, 32nd,47th day of the study

Secondary outcomes

1

Hemoglobin (Hb)

Iron status marker

Time frame
screening (-1), 16th, 32nd, 47th day of the study
2

Serum Ferritin (SF)

Iron status marker

Time frame
screening (-1), 16th, 32nd, 47th day of the study
3

Serum Transferrin Receptor (sTfR)

Iron status marker

Time frame
screening (-1), 47th day of the study
4

C-Reactive Protein (CRP)

Inflammation status

Time frame
screening (-1), 16th, 32nd, 47th day of the study

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Swiss Distance University of Applied Sciences

Lead sponsor

Swiss Federal Institute of Technology

Collaborator